Movexx SP Tablet is a combination medicine that relieves muscle, joint, and postoperative pain. It effectively alleviates pain and inflammation in conditions like rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis.
Movexx SP Tablet should be taken at the dose and duration advised by your doctor. It should be taken with food or milk to prevent stomach upset. Taking the medicine regularly at the correct times increases its effectiveness. It is important to continue taking it until your doctor tells you it is safe to stop.
Nausea, vomiting, stomach pain, indigestion, heartburn, increased liver enzymes, dizziness, drowsiness, and diarrhea are some common side effects that might be observed on taking this medicine. Your doctor may regularly monitor your kidney function, liver function, and blood component levels if you take this medicine for long-term treatment. Long-term use may lead to serious complications such as stomach bleeding and kidney problems. Movexx SP Tablet is not recommended if you are pregnant or breastfeeding.
Movexx SP Tablet is a combination medicine used for short-term relief of pain, inflammation, and swelling in conditions affecting joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis. Along with painkillers, this medicine also contains an active ingredient called Serratiopeptidase, which is an enzyme that promotes the overall healing process and speeds up recovery.
Take it as it is prescribed to get the most benefit. Do not take more or longer than needed as that can be dangerous. In general, you should take the lowest dose that works, for the shortest possible time. This will help you to go about your daily activities more easily and have a better, more active, quality of life.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Movexx SP Tablet is to be taken with food.
Movexx SP Tablet is a combination of three medicines: Aceclofenac, Paracetamol and Serratiopeptidase. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID), and Paracetamol is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme which works by breaking down abnormal proteins at the site of inflammation and promotes healing.
Alcohol
UNSAFE
It is unsafe to consume alcohol with Movexx SP Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Movexx SP Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Movexx SP Tablet during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
Movexx SP Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Movexx SP Tablet should be used with caution in patients with kidney disease. Dose adjustment of Movexx SP Tablet may be needed. Please consult your doctor.
Use of Movexx SP Tablet is not recommended in patients with severe kidney disease.
Liver
CAUTION
Movexx SP Tablet should be used with caution in patients with liver disease. Dose adjustment of Movexx SP Tablet may be needed. Please consult your doctor.
However, the use of Movexx SP Tablet is not recommended in patients with severe liver disease and active liver disease.
If you miss a dose of Movexx SP Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
